Trial intelligence / Profile preview

Levothyroxine supplementation in extremely preterm infants with transient hypothyroxinemia

2010-021228-89Phase 2Completed

Sponsor
Sant'Orsola-Malpighi University Hospital
Start
Mar 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial in Transient hypothyroxinemia (THOP) comparing Levothyroxine with Placebo (2 arms). Primary endpoints: Mental development score at 24 months corrected age and Psychomotor development score at 24 months corrected age. Started Mar 2012; status: completed.

02

Drugs

levothyroxine sodium
03

Conditions

Transient hypothyroxinemia (THOP)

Beyond the preview

Go deeper on 2010-021228-89.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-021228-89.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call